Tractor Supply Co.'s stock slides 5% premarket after sales miss, lowered guidance
Tractor Supply Co.'s stock (TSCO) fell 5% early Thursday, after the retailer of farm and ranch products . Brentwood, Tenn.-based Tractor Supply had net income of $255 million, or $2.33 a share, for the quarter, up from $234.1 million, or $2.10 a share, in the year-earlier period. Sales rose 4.3% to $3.41 billion. The FactSet consensus was for EPS of $2.29 and sales of $3.47 billion. CEO Hal Lawton said sales were lower than expected. "Given this environment, we have updated our outlook for the year to reflect continued unfavorable seasonal category performance and discerning consumer spending," he said in a statement. The company is now expecting full-year EPS of $10.00 to $10.10, down from prior guidance of $10.20 to $10.40. It expects sales of $14.5 billion to $14.6 billion, down from prior guidance of $14.8 billion to $14.9 billion. Same-store sales are expected to be flat, versus prior guidance of up 1.3% to 2.5%. The stock has fallen 12% in the year to date, while the S&P 500 has gained 9%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-26-23 0731ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk